Evidence map›Paper›PMID 16141003›Full record

ArticleJournal of medical genetics2005

Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.

G Piluso, L Politano, S Aurino, M Fanin, E Ricci, V M Ventriglia, A Belsito, A Totaro, V Saccone, H Topaloglu and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Review
  3. RecurrentInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

G PilusoDipartimento di Patologia Generale e Centro di Eccellenza per le malattie cardiovascolari, Seconda Università di Napoli, Naples, Italy.
L Politano
S Aurino
M Fanin
E Ricci
V M Ventriglia
A Belsito
A Totaro
V Saccone
H Topaloglu
A C Nascimbeni
L Fulizio
A Broccolini
N Canki-Klain
L I Comi
G Nigro
C Angelini
V Nigro
Telethon Institute Of Genetics And Medicine · ITRegione Campania · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Naples Federico II · ITUniversity of Padua · ITVeneto Institute of Molecular Medicine · ITHacettepe University Hospital · TRInstitute for Medical Research and Occupational Health · HR

Funding

Telethon GTF02009Telethon TGM03P11Telethon TGM06S01
6 · The paper itself

Abstract

backgroundThe limb girdle muscular dystrophies (LGMD) are a heterogeneous group of Mendelian disorders highlighted by weakness of the pelvic and shoulder girdle muscles. Seventeen autosomal loci have been so far identified and genetic tests are mandatory to distinguish among the forms. Mutations at the calpain 3 locus (CAPN3) cause LGMD type 2A.

objectiveTo obtain unbiased information on the consequences of CAPN3 mutations. PATIENTS: 530 subjects with different grades of symptoms and 300 controls.

methodsHigh throughput denaturing HPLC analysis of DNA pools.

results141 LGMD2A cases were identified, carrying 82 different CAPN3 mutations (45 novel), along with 18 novel polymorphisms/variants. Females had a more favourable course than males. In 94% of the more severely affected patient group, the defect was also discovered in the second allele. This proves the sensitivity of the approach. CAPN3 mutations were found in 35.1% of classical LGMD phenotypes. Mutations were also found in 18.4% of atypical patients and in 12.6% of subjects with high serum creatine kinase levels.

conclusionsA non-invasive and cost-effective strategy, based on the high throughput denaturing HPLC analysis of DNA pools, was used to obtain unbiased information on the consequences of CAPN3 mutations in the largest genetic study ever undertaken. This broadens the spectrum of LGMD2A phenotypes and sets the carrier frequency at 1:103.

Indexed as

PhenotypeAdultCalpainChromatography, High Pressure LiquidCohort StudiesDNAFemaleGenes, RecessiveGenetic TestingHumansMaleMuscle ProteinsMuscular Dystrophies, Limb-GirdleMutationPolymorphism, GeneticCalpainCAPN3 protein, humanDNAMuscle Proteins

Identifiers

PMID16141003
PMCPMC1736133
OpenAlexW2151185644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.